Taysha Gene Therapies, Inc.
TSHA$1.84B
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaDALLAS
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 11, 2026
6dMarket Overview
Stock performance and key metrics
TSHA News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
TSHA Earnings Report
Aug 11, 2026Confirmed
EPS Est: $-0.11 | FQ end 2026-06
How TSHA's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Taysha Gene Therapies, Inc.'s next FDA catalyst?→
Taysha Gene Therapies, Inc.'s (TSHA) next tracked catalyst is a Earnings expected August 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TSHA biotech catalysts?→
Add TSHA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Taysha Gene Therapies, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply